Assembly Biosciences reported a quarterly loss of $0.54 per share, beating the Zacks Consensus Estimate of a $0.73 loss by $0.19 per share. The loss also narrowed materially from $1.17 per share a year ago, indicating improved profitability trends. The report is modestly positive for the stock and may support a short-term reaction.
Assembly Biosciences reported a quarterly loss of $0.54 per share, beating the Zacks Consensus Estimate of a $0.73 loss by $0.19 per share. The loss also narrowed materially from $1.17 per share a year ago, indicating improved profitability trends. The report is modestly positive for the stock and may support a short-term reaction.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
